At the end of 2023, the FDA announced the creation of a digital health advisory committee, which will help the agency better understand the risks and benefits of emerging health care technology such as artificial intelligence and virtual reality.
This Advisory Committee will advise the FDA on a wide range of technologies such as artificial intelligence and machine learning, virtual reality, or wearables; and issues such as decentralized clinical trials, patient generated health data, or cybersecurity.
Recent Posts
The Government Is Shutdown, Now What?
Congress has failed to avert a government shutdown. The Department of Health and Human Services (HHS) is expected to face significant workforce reductions across its…
Meet the Academy Board of Directors
The American Academy of Audiology is proud to announce its Board of Directors, a group of dedicated leaders guiding the profession forward and ensuring the…
How Government Shutdown Could Affect Hearing Health Services
A partial U.S. government shutdown appears imminent as Congress has narrowly failed to reach agreement on a continuing resolution ahead of the October 1 funding…